CORONA Remedies Limited — Updates, 30-06-2026: Press Release
30-06-2026 | 04:49 pm
30-06-2026 | 04:49 pm
CORONA Remedies commenced commercial production at its EU-GMP approved Women's Hormone facility. The state-of-the-art plant strengthens manufacturing capabilities for domestic and international markets, expected to boost in-house hormone manufacturing capacity by 20%.
No comments yet. Be the first to comment!
